New drug corresponding disease

Showing 1–12 of 201 results

  • Myelodysplastic syndrome

    5-azacytidine

    [product name] RONG

    [English common name]5-azacytidine

    [Chinese common name]5-azacytidine

    [English name]4-Amino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one

    [Chinese other name]

    [Indications] for the treatment of ulcerative colitis, Crohn's disease; suppositories for the treatment of ulcerative proctitis, can also be combined with mesalazine tablets.

    [Usage and Dosage] Oral: Adult, ulcerative colitis (acute attack): 4 times a day, 1g each time; maintenance treatment, 3 times a day, 0.5g each time.
    Crohn's disease: 4 times a day, 1g each time. For children over 2 years old, take 20-30mg per kilogram of body weight per day, in divided doses.
    Suppository: Adult, 1-2 times a day, 1 suppository each time. Children over the age of two, follow the doctor's advice.

    [Storage] The tablets should be stored at room temperature (15-25 °C) and should not be taken after the expiration date. Suppositories should be stored at room temperature (15-25 °C) in the original package and should not be used after the expiration date.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Breast cancer

    Ado-trastuzumab

    【Product name】Kadcyla

    [English common name]Ado-trastuzumab emtansine

    [Chinese common name]Ado-trastuzumab

    [English name]

    [Chinese other name]

    [indications] metastaticBreast cancer: This product is suitable for HER2-positive metastatic breast cancer: metastatic breast cancer that has received one or more chemotherapy regimens as a single drug; combined with paclitaxel or docetaxel for metastasis without chemotherapy Breast cancer patients.
    Adjuvant therapy for breast cancer: This product is suitable for the adjuvant treatment of HER2 overexpressing breast cancer after surgery, adjuvant chemotherapy with anthracyclines and radiotherapy (if applicable).
    Metastatic gastric cancer: This product is combined with capecitabine or 5-fluorouracil and cisplatin for patients with metastatic gastric adenocarcinoma or gastroesophageal junction adenocarcinoma who have not received HER2 overexpression for the treatment of metastatic disease.
    Trastuzumab can only be used in patients with metastatic gastric cancer with HER2 overexpression, and HER2 overexpression is defined as IHC3+ or IHC2+/FISH+ results obtained using validated assays.

    [Usage and Dosage] Please fully dilute the reconstituted drug after the requirement of 'infusion preparation'.
    Do not push or push the vein quickly.
    HER2 testing should be performed prior to treatment with this product.
    The use of any other biological substitutes requires the consent of the prescribing physician.
    This product should be administered by intravenous infusion.
    Metastatic breast cancer
    Weekly dosing schedule
    Initial load dose: It is recommended that the initial load of this product is 4mg/kg. Intravenous infusion for more than 90 minutes.
    Maintenance dose: This product is recommended to be used at a dose of 2 mg/kg per week. If the initial load is tolerable, the dose can be infused intravenously for 30 minutes. Maintain treatment until disease progression.

    [Storage] Store in the refrigerator (2 ° C – 8 ° C).

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Multiple myeloma

    A-protease inhibitor

    【Product name】Zemaira

    [English common name]a lpha1-proteinase

    [Chinese common name]A-protease inhibitor

    [English name]

    [Chinese other name]

    [Indications] It is used to alleviate lung damage in patients with severe diseases.

    [Usage and Dosage] The recommended dose is 60 mg per kg of body weight, once a week. The infusion should last for about 15 minutes.

    [Storage] ZemairaTM remains stable for the life of the label when stored at temperatures up to 25 ° C (77 ° F). Avoid freezing, otherwise the container of the thinner may be damaged.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Adult hereditary angioedema (HAE)

    C1 lipase inhibitor

    【Product name】Berinert

    [English common name]Complement C1 esterase inhibitor

    [Chinese common name]C1 lipase inhibitor

    [English name]Cinryze, Ruconest

    [Chinese other name]

    [indications]Berinert is a plasma-derived concentrate of C1 esterase inhibitor (human) for the treatment of adult and adolescent patients.Hereditary angioedema (HAE)Acute abdominal or facial attack.

    【Dosage】

    [Storage]When the storage temperature is 2-25 ° C (36-77 ° F), Berinert remains stable over the shelf life of the carton and vial labels (up to 30 months).Keep the Berinert in the original carton until it is ready for use.Do not freeze.Protected from light.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Placeholder
    Multiple myeloma

    Marizomib

    【Product name】

    [English common name]Marizomib

    [Chinese common name]

    [English name]NPI-0052, NPI0052, NPI-0052, UNII-703P9YDP7F

    [Chinese other name]

    [indications]

    【Dosage】

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Cushing's disease

    Metyrapone / 美替拉酮

    中文名称：美替拉酮
    英文名称：Metyrapone
    适  应  症：用于库欣综合症的治疗。
    品  牌  商：诺华/HRA
    生  产  厂：诺华/HRA
    产        地：法国
    规        格：250mg*50s

    适  应  症：美替拉酮一般用于治疗库欣综合症。可用于鉴别由垂体而引起的肾上腺皮质功能不全。

    用法用量：每次750mg，每4小时服1次，共6次。儿童15mg/kg。本品也可用于库欣综合征的治疗。每次0.2g，1日2次。可根据病情况调整用量到1次1g，1日4次。常用其胶囊剂，每胶囊250mg。口服，500～700mg/次，一次/6h，服1～2d。

  • 慢性心衰

    Nebivolol / 奈必洛尔片

    【商品名】Bystolic

    【英文通用名】Nebivolol

    【中文通用名】奈必洛尔

    [English name]

    【适应症】可以防止心跳变得太快并调节心率。它还可以扩张血管，这也有助于降低血压。该药物还用于治疗 70 岁及以上患者的轻度和中度慢性心力衰竭（心力衰竭）。

    【用法用量】始终完全按照医生告诉您的方式服药。如果您不确定，请咨询您的医生。
    治疗高血压（高血压）
    通常的剂量是每天 1 片。如果可能，应在一天的同一时间服用该剂量。
    老年患者和肾病患者通常每天服用 1/2（半片）片剂。
    治疗 1 至 2 周后，降血压效果变得明显。有时，仅在 4 周后才能达到最佳效果。
    治疗慢性心力衰竭（心力衰竭）
    一位经验丰富的医生将开始并密切监测您的治疗。
    您的医生将以每天 1/4（四分之一）片开始您的治疗。1 – 2 周后，每日剂量可增加至 1/2（半片），然后根据需要增至 1 片，然后根据需要增至 2 片，直至达到适合您的剂量。您的医生会在每一步为您开出正确的剂量，您应该仔细遵循他/她的指示。
    最大推荐剂量为每天 2 片（10 毫克）。
    在治疗开始时和每次增加剂量时，必须由有经验的医生仔细监测 2 小时。

    【Tips】Part of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctor's face diagnosis. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Placeholder
    Pancreatic cancer

    Necuparanib

    【Product name】

    [English common name] Necuparanib

    [Chinese common name]

    [English name]

    [Chinese other name]

    [indications]

    【Dosage】

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Multiple sclerosis

    Ocrelizumab

    [product name] ocreves

    [English common name] ocrelizumab

    [Chinese common name]

    [English name]

    [Chinese other name]

    [Indications] Ocrevus is a treatmentMultiple sclerosisThe drug – Multiple Sclerosis is a neurological inflammatory disease that can cause symptoms such as weakness, difficulty walking and vision problems.
    Ocrevus is used in two groups of patients: adults with relapsing multiple sclerosis (RMS) who have a sudden onset (relapse) and then have a mild or asymptomatic period; with primary progressive multiple sclerosis (PPMS) Adults, as time goes on, the symptoms will gradually deteriorate.
    Ocrevus contains the active substance ocrelizumab.

    [Usage and Dosage] Ofcrevus enters the vein as an infusion (drop). The first two infusions were separated for two weeks and then infused every six months. Other medications (corticosteroids and antihistamines) are given to patients prior to each infusion to help prevent potentially dangerous reactions. If a reaction occurs during the infusion, a slower response can be stopped or given. Patients should be monitored during the infusion process and monitored at least one hour thereafter, and facilities that manage severe reactions should be readily available.

    [Storage]

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Non-myeloid malignancy

    TBO-cell colony stimulating factor

    【Product name】Granix

    [English common name]Tbo-filgrastim

    [Chinese common name]TBO-Fogstone

    [English name]

    [Chinese other name]

    [indications]
    Recombinant human granulocyte colony-stimulating factor injection:
    1. Cancer chemotherapy and other reasons lead toNeutropeniaCancer patients use myelosuppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the granulocyte The duration of the deficiency accelerates the recovery of granulocyte counts, thereby reducing the risk of fever associated with infection.
    2. Promote an increase in the number of neutrophils after bone marrow transplantation.
    3. Neutropenia caused by myelodysplastic syndrome, neutropenia caused by aplastic anemia, congenital, idiopathic neutropenia, myelodysplastic syndrome with neutral Agranulocytopenia, periodic neutropenia.
    TBO-granulocyte colony-stimulating factor pre-filled syringe: GRANIX (TBO-granulocyte colony-stimulating factor) is a clinically significant anti-myeloablative disease with the incidence of myelosuppression with febrile neutropenia The duration of severe neutropenia in cancer drugs is indicative of leukocyte growth factor.

    【Dosage】
    Recombinant human granulocyte colony-stimulating factor injection: The product is administered subcutaneously or intravenously 24 to 48 hours after the end of administration of the chemotherapy drug, once a day. The dosage and time of administration of this product should be determined according to the intensity of chemotherapy and the degree of neutrophil decline. For patients with greater chemotherapy intensity or decreased granulocyte count, it is more suitable to continue to take the drug for more than 7 days at a dose of 2.5 μg/kg body weight/day until the neutrophil is restored to 5000/mm3; if the dose of chemotherapy drug is used Lower, estimated to cause less severe myelosuppression, consider using a lower dose to prevent neutropenia, 1.25μg / kg body weight / day dose to the neutrophil number is stable in a safe range, Patients with significantly reduced neutrophils after chemotherapy (neutrophil count <1000/mm3).
    TBO-granulocyte colony stimulating factor prefilled syringe:
    Recommended dose: 5 micrograms per kilogram per day for subcutaneous injection.
    Myelosuppressive chemotherapy was administered no earlier than 24 hours after the first dose was administered. Do not give chemotherapy for the first 24 hours.

    [Storage]
    Recombinant human granulocyte colony-stimulating factor injection: sealed and preserved.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • Congenital factor XIII deficiency , hemophilia

    Human coagulation factor XIII

    【Product name】Corifact

    [English common name]Factor XIII concentrate

    [Chinese common name]Human coagulation factor XIII concentrate

    [English name]

    [Chinese other name]

    [indications]Congenital factor XIII deficiencyThe patient's hemorrhage.

    [Usage and dosage] is only for intravenous use. Formulated before use.
    Initial dose
    (1) 40 international units (units) per kilogram of body weight
    (2) Dosage rate should not exceed 4 mL per minute
    Subsequently administered
    (1) The application of the recent glutathione FXIII activity level was used to guide administration, and the dosing level was maintained at 5% to 20% every 28 days (4 weeks). It is recommended that the FXIII activity level be <5% or >20%, and the patient's clinical condition should be adjusted by ±5 units per kg of drug administration.
    (2) Dosing adjustments should be guided according to the specific analysis used to determine FXIII levels. Table 1 below is an overview of an example of a dose adjustment using Berichrom® activity analysis.
    Preparation and preparation
    (1) The storage vial is in the original box and in the refrigerator at 2-8 ° C (36-46 ° F). Do not freeze.
    (2) Prepare Corifact with USG 20 mL sterile water for injection before use.
    Administration
    (1) Do not mix with other drugs. Administered by separate infusion lines.

    [Storage]
    (1) Store the Corifact in the refrigerator at 2 – 8 ° C (36 – 46 ° F). Corifact is stable for 24 months until the expiration date on the box and vial label. Within the deadline, Corifact can be stored at room temperature not exceeding 25 ° C (77 ° F) for up to 6 months.
    (2) Do not put it back in the refrigerator when the product is stored at room temperature. Clearly mark the date of storage at room temperature on the label of the box.
    (3) Do not use more than the expiration date on the box and vial label, or r the end of the room storage period to see which one expires first.
    (4) In order to protect from light, store the vial in the original box. Do not freeze.
    (5) Immediately after administration. This product does not contain preservatives. This product must be used within 4 hours of preparation. Do not put the prepared solution in the refrigerator or freeze it.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

  • glaucoma

    Fluprostin

    【Product name】Zioptan

    [English common name]Tafluprost ophthalmic

    [Chinese common name]Fluprostin

    [English name]Tafluprost

    [Chinese other name]Fluoroprost

    [indications]Open angle type for patients with reduced intraocular pressureglaucomaOr high ocular hypertension.

    【Dosage】The recommended dose is one drop of conjunctival sac in the eye, once a day, at night. The dose should not exceed once a day as it has been shown that frequent administration of prostaglandin analogues may reduce the effects of decreased intraocular pressure.

    [Storage]Sealed and stored at 2-8 ° C (36-46 ° F). Store in the original pouch. Once the pouch is opened, the disposable container can be stored in an open foil pouch for up to 28 days at room temperature: 20-25 ° C (68-77 ° F). Moisture proof. Make a note of the date the aluminum foil bag was opened in the space provided on the pouch. Discard any unused containers 28 days after opening the bag for the first time.

    [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.